Serinus Biosciences

Biotechnology Research • United States • 1-10 Employees

Company overview

Headquarters	United States
Website	serinus.bio
NAICS	541714
Keywords	Drug Development, Small Molecules, Precision Medicine, Computational Biology, Cancer Biology, Ai/Ml, Genai, Protein-Protein Interactions
Founded	2022
Employees	1-10
Socials

Key Contact at Serinus Biosciences

Adam Yaari

Co-Founder & CEO

Serinus Biosciences Email Formats

Serinus Biosciences uses 2 email formats. The most common is {first name} (e.g., john@serinus.bio), used 66.7% of the time.

Format	Example	Percentage
{first name}	john@serinus.bio	66.7%
{first initial}	j@serinus.bio	33.3%

About Serinus Biosciences

Serinus Biosciences is an AI drug discovery company designing small molecule disrupters for protein-protein interactions (PPI). Our proprietary proteome-wide interface energetics map transforms any natural protein ligand into a small molecule binding opportunity. With over 60% of the proteome estimated to have binding hot loops at small molecule scale, we are geared to reveal orthosteric docking sites in tens of thousands of previously undruggable targets. Together with our PPI-specific generative AI engine, we design potent and synthetically accessible interface binding hits in months instead of years.

Serinus Biosciences revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	$650,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Serinus Biosciences has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Serinus Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2022-10-07	1	N/A
2022-10-07	2	$500,000
2023-12-16	1	$150,000

Funding Insights

$650,000

Total funding amount

$150,000

Most recent funding amount

Number of funding rounds

Serinus Biosciences Tech Stack

Discover the technologies and tools that power Serinus Biosciences's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

Emotion

Development

Squarespace Commerce

Ecommerce

reCAPTCHA

Security

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Cart Functionality

Ecommerce

Frequently asked questions

Serinus Biosciences is located in US.

Serinus Biosciences was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

Serinus Biosciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Serinus Biosciences has raised a total of $650,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Serinus Biosciences

Adam Yaari

Co-Founder & CEO

4.8

40,000 users